| Authors: |
Manchanda R; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; 4MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, Faculty of Population Health Sciences, University College London, London, UK.; 5Department of Gynecology, All India Institute of Medical Sciences, New Delhi, India., Sun L; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Sobocan M; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK.; 6Division of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia., Rodriguez IV; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Wei X; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Kalra A; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Oxley S; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Sideris M; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Fierheller CT; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Morgan RD; 8Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Chandrasekaran D; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK., Rust K; 9Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, University of Edinburgh, Scotland, UK., Spiliopoulou P; 10School of Cancer Sciences, University of Glasgow, Scotland, UK., Miller RE; 11Department of Medical Oncology, Barts Health NHS Trust, London, UK., Crusz SM; 11Department of Medical Oncology, Barts Health NHS Trust, London, UK., Lockley M; 12Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK., Singh N; 13Department of Pathology, Barts Health NHS Trust, London, UK., Faruqi A; 13Department of Pathology, Barts Health NHS Trust, London, UK., Casey L; 13Department of Pathology, Barts Health NHS Trust, London, UK., Brockbank E; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Phadnis S; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 2Department of Gynecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK., Mills-Baldock T; 14Department of Medical Oncology, Barking, Havering, and Redbridge University Hospitals, Essex, UK., El-Khouly F; 14Department of Medical Oncology, Barking, Havering, and Redbridge University Hospitals, Essex, UK., Jenkins LA; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Wallace A; 16Manchester Centre for Genomic Medicine, Division of Evolution, Infection, and Genomic Sciences, University of Manchester, Manchester, UK., Ahmed M; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Kumar A; 15North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK., Swisher EM; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Gourley C; 9Institute of Genetics and Cancer, Cancer Research UK Edinburgh Centre, University of Edinburgh, Scotland, UK., Norquist BM; 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA., Evans DG; 16Manchester Centre for Genomic Medicine, Division of Evolution, Infection, and Genomic Sciences, University of Manchester, Manchester, UK., Legood R; 1Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK.; 3Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. |
